CSVC

China-Singapore Suzhou Industrial Park Ventures (CSVC) is a prominent venture capital and private equity firm based in Suzhou, China, serving as the investment flagship of Suzhou Oriza Holdings. Founded in 2001, the firm has played a pivotal role in the development of the Suzhou BioBay ecosystem, one of China's leading biotechnology hubs. CSVC focuses on early-stage and growth-stage investments across the life sciences, healthcare, and high-technology sectors. Its portfolio includes some of China's most successful biotech companies, such as Innovent Biologics, JW Therapeutics, and Ascentage Pharma. The firm provides comprehensive financial solutions, including equity and debt investments, to support innovation and commercialization in the Chinese healthcare industry.